The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAGENE INC | ADS | 005329107 | 2,766 | 204,000 | SH | SOLE | 204,000 | 0 | 0 | ||
ADOBE SYSTEMS INCORPORATED | COM | 00724F101 | 371,772 | 634,813 | SH | SOLE | 634,813 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 14,575 | 2,094,100 | SH | SOLE | 2,094,100 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 54,419 | 987,456 | SH | SOLE | 987,456 | 0 | 0 | ||
AJAX I | COM | G0190X100 | 29,902 | 3,002,193 | SH | SOLE | 3,002,193 | 0 | 0 | ||
ALPHABET INC | CAP STK CL C | 02079K107 | 268,600 | 107,169 | SH | SOLE | 107,169 | 0 | 0 | ||
ALTIMETER GROWTH CORP | CL A | G0370L108 | 20,513 | 1,753,264 | SH | SOLE | 1,753,264 | 0 | 0 | ||
ALUSSA ENERGY ACQUISITION CO | SHS CL A | G0232J101 | 9,910 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
AMAZON COM INC | COM | 023135106 | 358,145 | 104,107 | SH | SOLE | 104,107 | 0 | 0 | ||
AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 22,923 | 1,169,529 | SH | SOLE | 1,169,529 | 0 | 0 | ||
AMERISOURCEBERGEN CORP | COM | 03073E105 | 134,481 | 1,174,605 | SH | SOLE | 1,174,605 | 0 | 0 | ||
ANALOG DEVICES INC | COM | 032654105 | 53,652 | 311,640 | SH | SOLE | 311,640 | 0 | 0 | ||
ANAPLAN INC | COM | 03272L108 | 106,896 | 2,005,548 | SH | SOLE | 2,005,548 | 0 | 0 | ||
APPLE INC | COM | 037833100 | 99,638 | 727,500 | SH | SOLE | 727,500 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,072 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,106 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BENITEC BIOPHARMA INC | COM | 08205P100 | 3,268 | 769,000 | SH | SOLE | 769,000 | 0 | 0 | ||
BLUE OWL CAPITAL INC | COM CL A | 09581B103 | 12,880 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 40,057 | 1,252,575 | SH | SOLE | 1,252,575 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 14,750 | 954,089 | SH | SOLE | 954,089 | 0 | 0 | ||
CANO HEALTH INC | *W EXP 06/03/202 | 13781Y111 | 2,488 | 674,566 | SH | SOLE | 674,566 | 0 | 0 | ||
CANO HEALTH INC | COM CL A | 13781Y103 | 86,659 | 7,161,896 | SH | SOLE | 7,161,896 | 0 | 0 | ||
CARVANA CO | CL A | 146869102 | 144,766 | 479,643 | SH | SOLE | 479,643 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 6,602 | 825,241 | SH | SOLE | 825,241 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 13,668 | 968,023 | SH | SOLE | 968,023 | 0 | 0 | ||
CLIMATE CHANGE CRISIS REAL I | CL A COM | 18716C100 | 3,004 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
COPART INC | COM | 217204106 | 109,189 | 828,255 | SH | SOLE | 828,255 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 3,745 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
DECIBEL THERAPEUTICS INC | COM | 24343R106 | 2,267 | 263,600 | SH | SOLE | 263,600 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 23,893 | 652,635 | SH | SOLE | 652,635 | 0 | 0 | ||
ELLIOTT OPPORTUNITY II CORP | UNIT 99/99/9999 | G30092129 | 1,502 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 35 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 984 | 99,999 | SH | SOLE | 99,999 | 0 | 0 | ||
EUROPEAN BIOTECH ACQUTN CORP | *W EXP 03/06/202 | G3167F128 | 95 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
EUROPEAN BIOTECH ACQUTN CORP | CLASS A ORD SHS | G3167F102 | 2,922 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 60,589 | 487,400 | SH | SOLE | 487,400 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 12,391 | 1,378,332 | SH | SOLE | 1,378,332 | 0 | 0 | ||
FACEBOOK INC | CL A | 30303M102 | 161,087 | 463,280 | SH | SOLE | 463,280 | 0 | 0 | ||
FIDELITY NATL INFORMATION SV | COM | 31620M106 | 85,002 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
FINSERV ACQUISITION CORP II | *W EXP 02/17/202 | 31809Y111 | 328 | 273,149 | SH | SOLE | 273,149 | 0 | 0 | ||
FINSERV ACQUISITION CORP II | COM CL A | 31809Y103 | 10,631 | 1,092,600 | SH | SOLE | 1,092,600 | 0 | 0 | ||
FINTECH ACQUISITION CORP V | COM CL A | 31810Q107 | 20,258 | 1,661,845 | SH | SOLE | 1,661,845 | 0 | 0 | ||
FIVE BELOW INC | COM | 33829M101 | 5,921 | 30,636 | SH | SOLE | 30,636 | 0 | 0 | ||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 896 | 84,000 | SH | SOLE | 84,000 | 0 | 0 | ||
FOLEY TRASIMENE ACQUISTN COR | *W EXP 05/26/202 | 34431F112 | 1,611 | 774,375 | SH | SOLE | 774,375 | 0 | 0 | ||
FOLEY TRASIMENE ACQUISTN COR | COM CL A | 34431F104 | 78,636 | 8,048,673 | SH | SOLE | 8,048,673 | 0 | 0 | ||
FORTE BIOSCIENCES INC | COM | 34962G109 | 17,380 | 516,956 | SH | SOLE | 516,956 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 32 | 29,166 | SH | SOLE | 29,166 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | CL A SHS | G3710A105 | 854 | 87,498 | SH | SOLE | 87,498 | 0 | 0 | ||
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 3,992 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 17,056 | 1,627,444 | SH | SOLE | 1,627,444 | 0 | 0 | ||
GEMINI THERAPEUTICS INC | COM | 36870G105 | 13,813 | 2,135,000 | SH | SOLE | 2,135,000 | 0 | 0 | ||
GFL ENVIRONMENTAL INC | SUB VTG SHS | 36168Q104 | 153,637 | 4,813,175 | SH | SOLE | 4,813,175 | 0 | 0 | ||
GLOBAL PMTS INC | COM | 37940X102 | 38,774 | 206,753 | SH | SOLE | 206,753 | 0 | 0 | ||
GORES HOLDINGS VI INC | COM CL A | 38286R105 | 42,986 | 2,651,800 | SH | SOLE | 2,651,800 | 0 | 0 | ||
GRAPHITE BIO INC | COM | 38870X104 | 3,841 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
HEALTHCOR CATALIO ACQU CORP | CL A SHS | G44125105 | 2,955 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
HERON THERAPEUTICS INC | COM | 427746102 | 23,132 | 1,490,440 | SH | SOLE | 1,490,440 | 0 | 0 | ||
HOLICITY INC | COM CL A | 435063102 | 12,350 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
HOWMET AEROSPACE INC | COM | 443201108 | 57,248 | 1,660,800 | SH | SOLE | 1,660,800 | 0 | 0 | ||
INFLARX NV | COM | N44821101 | 9,756 | 3,285,000 | SH | SOLE | 3,285,000 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 6,223 | 365,172 | SH | SOLE | 365,172 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 12,553 | 441,065 | SH | SOLE | 441,065 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 42,403 | 1,038,770 | SH | SOLE | 1,038,770 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 58,014 | 1,719,944 | SH | SOLE | 1,719,944 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 144,141 | 594,837 | SH | SOLE | 594,837 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 28,539 | 1,191,101 | SH | SOLE | 1,191,101 | 0 | 0 | ||
KATAPULT HOLDINGS INC | COM | 485859102 | 32,474 | 3,004,034 | SH | SOLE | 3,004,034 | 0 | 0 | ||
KBR INC | COM | 48242W106 | 118,714 | 3,111,777 | SH | SOLE | 3,111,777 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 7,656 | 1,409,956 | SH | SOLE | 1,409,956 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 34,584 | 1,658,706 | SH | SOLE | 1,658,706 | 0 | 0 | ||
LAUDER ESTEE COS INC | CL A | 518439104 | 163,370 | 513,614 | SH | SOLE | 513,614 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 32,766 | 1,826,445 | SH | SOLE | 1,826,445 | 0 | 0 | ||
MARQETA INC | CLASS A COM | 57142B104 | 14,144 | 503,898 | SH | SOLE | 503,898 | 0 | 0 | ||
MASTERCARD INCORPORATED | CL A | 57636Q104 | 198,945 | 544,921 | SH | SOLE | 544,921 | 0 | 0 | ||
MEDTRONIC PLC | SHS | G5960L103 | 161,172 | 1,298,416 | SH | SOLE | 1,298,416 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 27,418 | 8,649,300 | SH | SOLE | 8,649,300 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 4,682 | 851,291 | SH | SOLE | 851,291 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 24,047 | 148,872 | SH | SOLE | 148,872 | 0 | 0 | ||
MISTER CAR WASH INC | COM | 60646V105 | 3,230 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
MOLECULAR PARTNERS AG | ADS | 60853G106 | 8,196 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 3,405 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 40,156 | 353,700 | SH | SOLE | 353,700 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 3,180 | 314,835 | SH | SOLE | 314,835 | 0 | 0 | ||
NEWHOLD INVESTMENT CORP | COM CL A | 651448102 | 7,530 | 750,706 | SH | SOLE | 750,706 | 0 | 0 | ||
NEXIMMUNE INC | COM | 65344D109 | 5,969 | 365,762 | SH | SOLE | 365,762 | 0 | 0 | ||
NXP SEMICONDUCTORS N V | COM | N6596X109 | 83,199 | 404,428 | SH | SOLE | 404,428 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 2,985 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
OPENDOOR TECHNOLOGIES INC | COM | 683712103 | 118,873 | 6,704,630 | SH | SOLE | 6,704,630 | 0 | 0 | ||
OTIS WORLDWIDE CORP | COM | 68902V107 | 214,703 | 2,625,693 | SH | SOLE | 2,625,693 | 0 | 0 | ||
OTONOMY INC | COM | 68906L105 | 5,325 | 2,387,700 | SH | SOLE | 2,387,700 | 0 | 0 | ||
PAYSAFE LIMITED | ORD | G6964L107 | 156,429 | 12,917,328 | SH | SOLE | 12,917,328 | 0 | 0 | ||
PELOTON INTERACTIVE INC | CL A COM | 70614W100 | 90,964 | 733,463 | SH | SOLE | 733,463 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 15,365 | 625,625 | SH | SOLE | 625,625 | 0 | 0 | ||
QUANTA SVCS INC | COM | 74762E102 | 115,190 | 1,271,834 | SH | SOLE | 1,271,834 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 5,070 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
REVOLUTION ACCELERTN ACQU CO | COM CL A | 76156P106 | 24,932 | 2,500,708 | SH | SOLE | 2,500,708 | 0 | 0 | ||
RH | COM | 74967X103 | 206,519 | 304,151 | SH | SOLE | 304,151 | 0 | 0 | ||
ROSS STORES INC | COM | 778296103 | 138,785 | 1,119,235 | SH | SOLE | 1,119,235 | 0 | 0 | ||
ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | 29,897 | 729,377 | SH | SOLE | 729,377 | 0 | 0 | ||
SANA BIOTECHNOLOGY INC | COM | 799566104 | 1,966 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SENTINELONE INC | CL A | 81730H109 | 29,793 | 701,000 | SH | SOLE | 701,000 | 0 | 0 | ||
SIO GENE THERAPIES INC | COMMON | 829399104 | 14,985 | 5,489,000 | SH | SOLE | 5,489,000 | 0 | 0 | ||
SOFI TECHNOLOGIES INC | COM | 83406F102 | 47,925 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
SOFI TECHNOLOGIES INC | COM | 83406F102 | 27,605 | 1,440,000 | SH | Put | SOLE | 1,440,000 | 0 | 0 | |
SOLID BIOSCIENCES INC | COM | 83422E105 | 21,866 | 5,974,193 | SH | SOLE | 5,974,193 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 31,889 | 1,715,381 | SH | SOLE | 1,715,381 | 0 | 0 | ||
TABOOLA.COM LTD | ORD SHS | M8744T106 | 3,623 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
TAPESTRY INC | COM | 876030107 | 225,220 | 5,179,862 | SH | SOLE | 5,179,862 | 0 | 0 | ||
TE CONNECTIVITY LTD | REG SHS | H84989104 | 81,738 | 604,527 | SH | SOLE | 604,527 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 13,794 | 1,125,136 | SH | SOLE | 1,125,136 | 0 | 0 | ||
THERAPEUTICS ACQUISITION COR | COM CL A | 88339T103 | 21,017 | 2,045,600 | SH | SOLE | 2,045,600 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 61 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 1,978 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
TURNING POINT THERAPEUTICS I | COM | 90041T108 | 9,596 | 122,994 | SH | SOLE | 122,994 | 0 | 0 | ||
TWILIO INC | CL A | 90138F102 | 123,766 | 314,000 | SH | SOLE | 314,000 | 0 | 0 | ||
UBER TECHNOLOGIES INC | COM | 90353T100 | 193,438 | 3,859,494 | SH | SOLE | 3,859,494 | 0 | 0 | ||
UNION PAC CORP | COM | 907818108 | 210,380 | 956,577 | SH | SOLE | 956,577 | 0 | 0 | ||
UNITEDHEALTH GROUP INC | COM | 91324P102 | 277,030 | 691,813 | SH | SOLE | 691,813 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 6,025 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
VIMEO INC | COMMON STOCK | 92719V100 | 80,359 | 1,639,972 | SH | SOLE | 1,639,972 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 11,062 | 594,111 | SH | SOLE | 594,111 | 0 | 0 |